European Commission (EC) has published a new version of the Questions & Answers document on “Safety Features for Medicinal Products for Human Use (V.19)”.
The document is available on EMVO’s website in the Knowledge Database section – Documents Overview.
The modifications from the previous version have been highlighted for your convenience.
The changes include the addition of a new Q&A (1.29) and the revision of Q&As 1.22, 5.8 and 7.19.
In case of any questions, please contact EMVO Helpdesk: helpdesk@emvo-medicines.eu